GAVI facts and figures

Every year, academics, journalists, teachers and students ask for statistics detailing Gavi's results since the Vaccine Alliance was established in 2000. Sourcing the Gavi Secretariat and members of the Vaccine Alliance, including WHO, UNICEF and civil society
organisations, these key facts and figures list Gavi's achievements to date as well as demonstrating the Vaccine Alliance's catalytic role within global immunisation.

US$ 80-100 billion

Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

Since 2000, 500 million children have been immunised through Gavi support to routine immunisation in the world's poorest countries.

Source: Gavi

11 million

Gavi support had contributed to immunising 11 million children against pneumococcal disease by the end of 2013.

Source: WHO/UNICEF

+243,000,000

Gavi support will assist countries to immunise a further 243 million children between 2011 and 2015.

Source: Gavi

73 countries

Gavi support is available to the 73 poorest countries in the world. By the end of 2013, 22 countries were projected to graduate from Gavi’s support by 2020.

Source: Gavi

US$ 9.6 billion

By the end of December 2014, the Vaccine Alliance had committed US$ 9.6 billion in programme support until 2020 to the world’s poorest countries.

Source: Gavi

3.9 million

Gavi support for vaccines will contribute to averting close to an estimated 3.9 million future deaths between 2011 and 2015.

Source: Gavi

+40%

Over the course of a decade, the weighted average price of pentavalent vaccine (DTP-hepB-Hib) dropped by 43% from US$ 3.56 per dose in 2003 to US$ 2.04 per dose in 2013, with a lowest-ever price of US$ 1.19 from one supplier in 2013.

Source: Gavi

1.5 million

In 2012, approximately 6.6 million children died before the age of five. WHO estimates that 1.5 million of these deaths are due to vaccine-preventable diseases.